Department of Health and Human Services February 2, 2010 – Federal Register Recent Federal Regulation Documents
Results 1 - 15 of 15
Implementation of Section 5001 of the American Recovery and Reinvestment Act of 2009 for Adjustments to the First Quarter of Fiscal Year 2010 Federal Medical Assistance Percentage Rates for Federal Matching Shares for Medicaid and Title IV-E Foster Care, Adoption Assistance and Guardianship Assistance Programs
This notice provides the adjusted Federal Medical Assistance Percentage (FMAP) rates for the first quarter of Fiscal Year 2010 (FY10) as required under Section 5001 of the American Recovery and Reinvestment Act of 2009 (ARRA). Section 5001 of the ARRA provides for temporary increases in the FMAP rates to provide fiscal relief to states and to protect and maintain state Medicaid and certain other assistance programs in a period of economic downturn. The increased FMAP rates apply during a recession adjustment period that is defined in ARRA as the period beginning October 1, 2008 and ending December 31, 2010.
Interim Final Rules Under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008
This document contains interim final rules implementing the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, which requires parity between mental health or substance use disorder benefits and medical/surgical benefits with respect to financial requirements and treatment limitations under group health plans and health insurance coverage offered in connection with a group health plan.
Brian Ullom: Debarment Order
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (the act) permanently debarring Brian Ullom from providing services in any capacity to a person that has an approved or pending drug product application. We base this order on a finding that Mr. Ullom was convicted of a felony under Federal law for conduct relating to the regulation of a drug product under the act. Mr. Ullom was given notice of the proposed permanent debarment and an opportunity to request a hearing within the timeframe prescribed by regulation. As of December 2, 2009, Mr. Ullom failed to respond. Mr. Ullom's failure to respond constitutes a waiver of his right to a hearing concerning this action.
Endocrinologic and Metabolic Drugs Advisory Committee; Cancellation
The meeting of the Endocrinologic and Metabolic Drugs Advisory Committee scheduled for February 24, 2010, is cancelled. This meeting was announced in the Federal Register of January 19, 2010 (75 FR 2875). This meeting has been cancelled due to unexpected delays in the preparation of materials for the meeting. The agency will reschedule this meeting and announce a future meeting date in the Federal Register.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.